Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
Rang in Aktien
#4178
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Aktienkurs
$2.26
Marktkapitalisierung
$3.78B
Veränderung (1 Tag)
-1.24%
Veränderung (1 Jahr)
-7.70%
Land
CN
Handel Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Kategorie
Healthcare
Kursverlauf für Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Höchster Schlusskurs: $2.22 am 2026-10-01
Niedrigster Schlusskurs: $1.96 am 2011-07-01
Niedrigster Schlusskurs: $1.96 am 2011-07-01
Kursverlauf der Aktie von Shijiazhuang Yiling Pharmaceutical Co., Ltd. von 2011 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -3.43% |
| 2025 | 9.44% |
| 2024 | -31.70% |
| 2023 | -43.84% |
| 2022 | 120.08% |
| 2021 | -1.11% |
| 2020 | 139.79% |
| 2019 | 3.52% |
| 2018 | -35.19% |
| 2017 | -5.82% |
| 2016 | -10.07% |
| 2015 | 12.01% |
| 2014 | -1.89% |
| 2013 | 45.33% |
| 2012 | -23.48% |
| 2011 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $63.48 | 72.30% |
US
|
|
| $45.98 | 36.92% |
SE
|
|
| $172.16 | 24.48% |
FR
|
|
| $59.52 | -0.48% |
IT
|
|
| $109.14 | 48.18% |
US
|
